betahistine has been researched along with Agitation, Psychomotor in 1 studies
Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There were no serious adverse events reported in the study, betahistine was safe and well tolerated at all the dose levels tested." | 2.80 | Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD. ( Desai, PB; Gabbita, P; Moorthy, G; Sallans, L; Sallee, F; Zemlan, F, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moorthy, G | 1 |
| Sallee, F | 1 |
| Gabbita, P | 1 |
| Zemlan, F | 1 |
| Sallans, L | 1 |
| Desai, PB | 1 |
1 trial available for betahistine and Agitation, Psychomotor
| Article | Year |
|---|---|
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD.
Topics: Acetates; Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Betahistine; D | 2015 |